Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19,767 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of viral rebounds on dual etravirine/raltegravir maintenance therapy (ANRS-163 ETRAL trial).
Soulie C, Assoumou L, Abdi B, Sayon S, Nguyen T, Valantin MA, Beniguel L, Ferre V, Alloui C, Montes B, Avettand-Fenoel V, Delaugerre C, Descamps D, Martinez E, Reynes J, Peytavin G, Costagliola D, Katlama C, Calvez V, Marcelin AG; ANRS-163 ETRAL study group. Soulie C, et al. Among authors: nguyen t. J Antimicrob Chemother. 2020 Jul 1;75(7):1943-1949. doi: 10.1093/jac/dkaa090. J Antimicrob Chemother. 2020. PMID: 32259255 Clinical Trial.
Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia.
Katlama C, Soulié C, Caby F, Denis A, Blanc C, Schneider L, Valantin MA, Tubiana R, Kirstetter M, Valdenassi E, Nguyen T, Peytavin G, Calvez V, Marcelin AG. Katlama C, et al. Among authors: nguyen t. J Antimicrob Chemother. 2016 Sep;71(9):2646-50. doi: 10.1093/jac/dkw186. Epub 2016 Jun 10. J Antimicrob Chemother. 2016. PMID: 27287235
Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation.
Jaffré J, Armenia D, Bellocchi MC, Wirden M, Carioti L, Lambert S, Valantin MA, Nguyen T, Simon A, Katlama C, Andreoni M, Perno CF, Calvez V, Ceccherini-Silberstein F, Marcelin AG, Todesco E. Jaffré J, et al. Among authors: nguyen t. J Antimicrob Chemother. 2017 May 1;72(5):1537-1539. doi: 10.1093/jac/dkw571. J Antimicrob Chemother. 2017. PMID: 28088769 Free article. No abstract available.
Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients.
Marcelin AG, Grude M, Charpentier C, Bellecave P, Le Guen L, Pallier C, Raymond S, Mirand A, Bocket L, Fofana DB, Delaugerre C, Nguyen T, Montès B, Jeulin H, Mourez T, Fafi-Kremer S, Amiel C, Roussel C, Dina J, Trabaud MA, Le Guillou-Guillemette H, Vallet S, Signori-Schmuck A, Maillard A, Ferre V, Descamps D, Calvez V, Flandre P; ANRS AC43 Resistance Group. Marcelin AG, et al. Among authors: nguyen t. J Antimicrob Chemother. 2019 May 1;74(5):1368-1375. doi: 10.1093/jac/dkz021. J Antimicrob Chemother. 2019. PMID: 30789205 Free article.
Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen.
Charpentier C, Malet I, Andre-Garnier E, Storto A, Bocket L, Amiel C, Morand-Joubert L, Tumiotto C, Nguyen T, Maillard A, Rodallec A, Leoz M, Montes B, Schneider V, Plantier JC, Dina J, Pallier C, Mirand A, Roussel C, Signori-Schmuck A, Raymond S, Calvez V, Delaugerre C, Marcelin AG, Descamps D. Charpentier C, et al. Among authors: nguyen t. J Antimicrob Chemother. 2018 Apr 1;73(4):1039-1044. doi: 10.1093/jac/dkx511. J Antimicrob Chemother. 2018. PMID: 29342281
19,767 results
You have reached the last available page of results. Please see the User Guide for more information.